Free Trial
OTCMKTS:RHHVF

Roche (RHHVF) Stock Price, News & Analysis

Roche logo
$326.42 +4.30 (+1.33%)
As of 04/29/2025 03:46 PM Eastern

About Roche Stock (OTCMKTS:RHHVF)

Key Stats

Today's Range
$319.63
$329.70
50-Day Range
$286.95
$351.50
52-Week Range
$233.12
$354.19
Volume
604 shs
Average Volume
4,726 shs
Market Capitalization
N/A
P/E Ratio
30.20
Dividend Yield
2.39%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Roche Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
2nd Percentile Overall Score

RHHVF MarketRank™: 

Roche scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Roche.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Roche is 30.20, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.71.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Roche is 30.20, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.41.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Roche has a short interest ratio ("days to cover") of 179.7, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Roche has recently increased by 30.79%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Roche pays a meaningful dividend of 3.21%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Roche does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Roche is 72.16%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Roche's dividend.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Roche has a short interest ratio ("days to cover") of 179.7, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Roche has recently increased by 30.79%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Roche has a news sentiment score of 0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.85 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Roche this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Roche insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Only 29.01% of the stock of Roche is held by institutions.

  • Read more about Roche's insider trading history.
Receive RHHVF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter.

RHHVF Stock News Headlines

UBS Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
Roche Holding AG (RHHVF) Receives a Buy from DZ BANK AG
UBS Remains a Buy on Roche Holding AG (RHHVF)
See More Headlines

RHHVF Stock Analysis - Frequently Asked Questions

Roche's stock was trading at $280.00 at the start of the year. Since then, RHHVF stock has increased by 16.6% and is now trading at $326.4168.
View the best growth stocks for 2025 here
.

Shares of RHHVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Ex-Dividend for 3/31 Dividend
3/27/2025
Record date for 3/31 Dividend
3/28/2025
Dividend Payable
3/31/2025
Today
4/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:RHHVF
CIK
N/A
Fax
N/A
Employees
103,605
Year Founded
N/A

Profitability

Trailing P/E Ratio
30.20
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (OTCMKTS:RHHVF) was last updated on 4/30/2025 by MarketBeat.com Staff
From Our Partners